Non-syndromic hearing loss caused by the dominant cis mutation R75Q with the recessive mutation V37I of the GJB2 (Connexin 26) gene
被引:7
|
作者:
Kim, Juwon
论文数: 0引用数: 0
h-index: 0
机构:
Yonsei Univ, Wonju Coll Med, Dept Lab Med, Wonju, South KoreaYonsei Univ, Wonju Coll Med, Dept Lab Med, Wonju, South Korea
Kim, Juwon
[1
]
论文数: 引用数:
h-index:
机构:
Jung, Jinsei
[2
,3
]
Lee, Min Goo
论文数: 0引用数: 0
h-index: 0
机构:
Yonsei Univ, Coll Med, Dept Pharmacol, Brain Korea Project Med Sci 21,Severance Biomed S, Seoul 120752, South KoreaYonsei Univ, Wonju Coll Med, Dept Lab Med, Wonju, South Korea
Lee, Min Goo
[3
]
Choi, Jae Young
论文数: 0引用数: 0
h-index: 0
机构:
Yonsei Univ, Coll Med, Dept Otorhinolaryngol, Seoul 120752, South KoreaYonsei Univ, Wonju Coll Med, Dept Lab Med, Wonju, South Korea
Choi, Jae Young
[2
]
Lee, Kyung-A
论文数: 0引用数: 0
h-index: 0
机构:
Yonsei Univ, Coll Med, Dept Lab Med, Seoul 120752, South KoreaYonsei Univ, Wonju Coll Med, Dept Lab Med, Wonju, South Korea
Lee, Kyung-A
[4
]
机构:
[1] Yonsei Univ, Wonju Coll Med, Dept Lab Med, Wonju, South Korea
[2] Yonsei Univ, Coll Med, Dept Otorhinolaryngol, Seoul 120752, South Korea
[3] Yonsei Univ, Coll Med, Dept Pharmacol, Brain Korea Project Med Sci 21,Severance Biomed S, Seoul 120752, South Korea
[4] Yonsei Univ, Coll Med, Dept Lab Med, Seoul 120752, South Korea
GJB2 alleles containing two cis mutations have been rarely found in non-syndromic hearing loss. Herein, we present a Korean patient with non-syndromic hearing loss caused by the R75Q cis mutation with V37I, which arose de novo in the father and was inherited by the patient. Biochemical coupling and hemichannel permeability assays were performed after molecular cloning and transfection of HEK293T cells. Student's t-tests or analysis of variance followed by Tukey's multiple comparison test was used as statistical analysis. Biochemical coupling was significantly reduced in connexin 26 (Cx26)-R75Q- and Cx26-V37I-transfected cells, with greater extent in Cx26-R75Q and Cx26-R75Q+V37I cells. Interestingly, our patient and his father with the mutations had more residual hearing compared with patients with the dominant mutation alone. Although the difference in hemichannel activity between R75Q alone and R75Q in combination with V37I failed to reach significance, it is of note that there is a possibility that V37I located upstream of R75Q might have the ability to ameliorate R75Q expression. Our study emphasizes the importance of cis mutations with R75Q, as the gene effect of R75Q can be modulated depending on the type of additional mutation.